MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
208.27%
Quick Ratio
208.27%
Cash Ratio
51.80%
Debt to Asset Ratio
27.79%
Unit: Thousand (K) dollars
Assets Breakdown
    • Intangible assets, net
    • Accounts receivable, net
    • Goodwill
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Retained earnings
    • Accounts payable and accrued lia...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
179,953
184,869
128,448
151,371
Marketable securities
192,114
199,372
180,222
129,789
Accounts receivable, net
211,656
182,183
187,802
171,254
Inventories, net
83,924
87,062
82,385
79,399
Prepaid expenses and other current assets
55,849
78,094
65,325
62,078
Total current assets
723,496
731,580
644,182
593,891
Restricted cash
1,450
1,450
1,450
1,450
Property and equipment, net
10,197
10,042
10,531
10,627
Intangible assets, net
469,459
549,712
569,456
623,481
Goodwill
119,431
120,668
124,882
119,080
Deferred income tax assets, net
49,061
30,820
38,351
8,793
Other assets
55,015
56,453
63,796
62,432
Total assets
1,428,109
1,500,725
1,452,648
1,419,754
Accounts payable and accrued liabilities
108,458
101,244
107,800
108,613
Accrued product returns and rebates
198,844
189,720
161,097
184,459
Contingent consideration, current portion
0
0
31,052
11,235
Other current liabilities
40,076
82,965
38,222
26,322
Total current liabilities
347,378
373,929
338,171
330,629
Contingent consideration, long-term
206
206
206
213
Operating lease liabilities, long-term
29,427
30,267
30,365
31,422
Deferred income tax liabilities, net
-
-
0
0
Other liabilities
19,872
19,518
22,192
7,823
Total liabilities
396,883
423,920
390,934
370,087
Common stock, 0.001 par value 130,000,000 shares authorized 58,164,352 and 57,457,462 shares issued and outstanding as of june 30, 2026 and december31, 2025, respectively
58
58
57
57
Additional paid-in capital
574,094
561,419
543,825
527,700
Accumulated other comprehensive loss, net of tax
-138
-255
-44
-71
Retained earnings
457,212
515,583
517,876
521,981
Total stockholders' equity
1,031,226
1,076,805
1,061,714
1,049,667
Total liabilities and stockholders' equity
1,428,109
1,500,725
1,452,648
1,419,754
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, net$211,656K (50.29%↑ Y/Y)Marketable securities$192,114K (-49.16%↓ Y/Y)Cash and cashequivalents$179,953K (24.35%↑ Y/Y)Inventories, net$83,924K (90.64%↑ Y/Y)Prepaid expenses andother current assets$55,849K (77.77%↑ Y/Y)Total current assets$723,496K (-2.08%↓ Y/Y)Intangible assets, net$469,459K (-2.46%↓ Y/Y)Goodwill$119,431K (2.06%↑ Y/Y)Other assets$55,015K (96.74%↑ Y/Y)Deferred income taxassets, net$49,061K (693.74%↑ Y/Y)Property and equipment,net$10,197K (-7.88%↓ Y/Y)Restricted cash$1,450K Total assets$1,428,109K (3.31%↑ Y/Y)Total liabilities andstockholders' equity$1,428,109K (3.31%↑ Y/Y)Total stockholders'equity$1,031,226K (-3.07%↓ Y/Y)Total liabilities$396,883K (24.61%↑ Y/Y)Accumulated othercomprehensive loss, net of tax-$138K (31.00%↑ Y/Y)Additional paid-in capital$574,094K (15.52%↑ Y/Y)Retained earnings$457,212K (-19.38%↓ Y/Y)Total currentliabilities$347,378K (21.31%↑ Y/Y)Operating leaseliabilities, long-term$29,427K (20.69%↑ Y/Y)Other liabilities$19,872K (156.02%↑ Y/Y)Contingent consideration,long-term$206K Common stock, 0.001 parvalue 130,000,000...$58K (3.57%↑ Y/Y)Accrued product returnsand rebates$198,844K (9.91%↑ Y/Y)Accounts payable andaccrued liabilities$108,458K (39.52%↑ Y/Y)Other currentliabilities$40,076K (44.65%↑ Y/Y)

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

SUPERNUS PHARMACEUTICALS, INC. (SUPN)